Does CARFILZOMIB Cause Electrocardiogram qt prolonged? 81 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Electrocardiogram qt prolonged have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.4% of all adverse event reports for CARFILZOMIB.
81
Reports of Electrocardiogram qt prolonged with CARFILZOMIB
0.4%
of all CARFILZOMIB reports
12
Deaths
27
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From CARFILZOMIB?
Of the 81 reports, 12 (14.8%) resulted in death, 27 (33.3%) required hospitalization, and 9 (11.1%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which CARFILZOMIB Alternatives Have Lower Electrocardiogram qt prolonged Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL